Form 4 for FENC FENNEC PHARMACEUTICALS INC.
Accepted 2026-03-26 00:00:00 ET · period of report 2026-03-26 · accession 0001468308-26-000016 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-26 | 2026-03-26 | FENC | Andrade Robert | CFO | M - OptEx | $5.10 | +13.1K | 256.7K | +5% | +$66.7K |
| D | 2026-03-26 | 2026-03-26 | FENC | Andrade Robert | CFO | M - OptEx | $5.10 | -13.1K | 801.0K | -2% | -$66.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares | 2026-03-26 | M | A | 13,072 | $5.10 | 256,656 | D | — | — | (F1) Shares acquired through the exercise of an option contract with strike price of $5.10 and an expiration date of June 27, 2027. |
| 2 | Derivative | Stock Options | 2026-03-26 | M | D | 13,072 | $5.10 | 801,045 | D | $5.10 · 2017-06-27 to 2027-06-27 | 13,072 Options | (F1) Shares acquired through the exercise of an option contract with strike price of $5.10 and an expiration date of June 27, 2027. |